Big Move For ORPH
Tue, Aug 10, 2021 at 05:30 PM
ORPH (ORPH:NASDAQ) rocketted at $5.22, a gain of 24.6%. On Mon, Aug 09, 2021, ORPH:NASDAQ hit a New 2-Week Intraday Low of $4.05. The stock appeared on our News Catalysts scanner on Tue, Aug 10, 2021 at 12:22 PM in the 'INVESTOR UPDATE' category. From Mon, Jul 26, 2021, the stock recorded 20.00% Up Days and 18.18% Green Days
The stock spiked on Fri, Jul 16, 2021 at $6.68 with a volume of 15M+, and its share price has been moving sideways in recent weeks.
About ORPH (ORPH:NASDAQ)
Orphazyme A/S is a Danish biotech company. It is engaged in the development of paradigm-changing medicines for the treatment of protein misfolding diseases.
Top 10 Gainers:
- Fulcrum Therapeutics, Inc. (FULC:NASDAQ), 125.33%
- ZEV (ZEV:NYSE), 80.97%
- SC Health Corporation (SCPE:NYSE), 53.11%
- Mediaco Holding Inc. (MDIA:NASDAQ), 36.3%
- Exagen Inc. (XGN:NASDAQ), 24.59%
- ORPH (ORPH:NASDAQ), 24.58%
- ACHL (ACHL:NASDAQ), 22.13%
- FSR (FSR:NYSE), 21.56%
- Cortexyme, Inc. (CRTX:NASDAQ), 21.53%
- 3D Systems Corporation (DDD:NYSE), 21.48%